Loading
Latest filing published 27 Jun 2022 for eFFECTOR Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Brian M. Gallagher Jr., listed as board member, appears in our data through filings on eFFECTOR Therapeutics, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 25 August 2021 to 23 June 2022.
The open-market record is one-sided, with 1 purchase and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. Since January 2022: 1 purchase and no sales on the market.
Most recently, on 27 June 2022, the filings show an open-market purchase in eFFECTOR Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations